Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 2
2018 4
2020 2
2021 1
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.
Hanniford D, Ulloa-Morales A, Karz A, Berzoti-Coelho MG, Moubarak RS, Sánchez-Sendra B, Kloetgen A, Davalos V, Imig J, Wu P, Vasudevaraja V, Argibay D, Lilja K, Tabaglio T, Monteagudo C, Guccione E, Tsirigos A, Osman I, Aifantis I, Hernando E. Hanniford D, et al. Among authors: berzoti coelho mg. Cancer Cell. 2020 Jan 13;37(1):55-70.e15. doi: 10.1016/j.ccell.2019.12.007. Cancer Cell. 2020. PMID: 31935372 Free PMC article.
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.
Cacemiro MDC, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Malta T, Tognon R, Nunes NS, Souto EX, de Figueiredo-Pontes LL, Yatsuda AP, de Castro FA. Cacemiro MDC, et al. Among authors: berzoti coelho mg. Med Oncol. 2022 May 23;39(5):97. doi: 10.1007/s12032-022-01696-x. Med Oncol. 2022. PMID: 35599283
Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Cominal JG, Cacemiro MDC, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, de Figueiredo-Pontes LL, Oliveira MC, Malmegrim KCR, de Castro FA. Cominal JG, et al. Among authors: berzoti coelho mg. Front Oncol. 2021 May 18;11:665037. doi: 10.3389/fonc.2021.665037. eCollection 2021. Front Oncol. 2021. PMID: 34084749 Free PMC article.
Differential cytokine network profile in polycythemia vera and secondary polycythemia.
Cacemiro MDC, Cominal JG, Berzoti-Coelho MG, Tognon R, Nunes NS, Simões B, Pereira ÍS, Carlos D, Faccioli LH, Figueiredo-Pontes LL, Frantz FG, Castro FA. Cacemiro MDC, et al. Among authors: berzoti coelho mg. Sci Rep. 2020 Apr 27;10(1):7032. doi: 10.1038/s41598-020-63680-7. Sci Rep. 2020. PMID: 32341381 Free PMC article.
Bioactive Lipids as Chronic Myeloid Leukemia's Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors.
de Almeida FC, Berzoti-Coelho MG, Toro DM, Cacemiro MDC, Bassan VL, Barretto GD, Garibaldi PMM, Palma LC, de Figueiredo-Pontes LL, Sorgi CA, Faciolli LH, Gardinassi LG, de Castro FA. de Almeida FC, et al. Among authors: berzoti coelho mg. Front Immunol. 2022 Apr 13;13:840173. doi: 10.3389/fimmu.2022.840173. eCollection 2022. Front Immunol. 2022. PMID: 35493444 Free PMC article.
Corrigendum to "The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms" [Blood Cells Mol. Dis. 59 (2016) 25-30].
Berzoti-Coelho MG, Ferreira AF, de Souza Nunes N, Tomazini Pinto M, Júnior MCR, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA. Berzoti-Coelho MG, et al. Blood Cells Mol Dis. 2018 Mar;69:123. doi: 10.1016/j.bcmd.2017.08.013. Epub 2017 Sep 4. Blood Cells Mol Dis. 2018. PMID: 28882478 No abstract available.
12 results